"Our recent FDA clearance for the patent pending Rejuvapen NXT is without a doubt, a game changer in the industry. Our device brings major technological advancements to the market with its multiple (9) speed settings, precise infinite dial, and digital motor. The health care provider now has the flexibility to customize each patient’s facial treatment to produce the consistent clinical results today’s consumers demand. We are proud to announce the Rejuvapen NXT is manufactured in the USA and we have positioned our unit and consumable pricing to be nearly 50 percent less than the other FDA cleared microneedling systems available today,” said Anthony Johnson, Refine USA president of Sales.
The Rejuvapen NXT has passed multiple electrical and safety tests for biocompatibility, including testing for irritation and cytotoxicity, and sensitization ensuring none of the materials used are harmful to the patient. These tests also include design verification and validation testing. The product is also certified according to ISO/IEC Guide 17067 and in accordance with ANSI/AAMI ES60601.
Microneedling has proven to be safe and effective. Patients can now experience fantastic results with a device that is not highly invasive. Benefits include:
- Safe and effective for all skin types
- Very little downtime
- Short procedure time
- Very little pain and discomfort
- Ideal for use any time of the year including the summer months with little restriction after treatment